Serge Saxonov 10x Genomics, Inc. (TXG) insider trading activity

Serge Saxonov is Chief Executive Officer of 10x Genomics, Inc.. Currently has a direct ownership of 955,240 shares of TXG, which is worth approximately $13.1 Million. The most recent transaction as insider was on Apr 06, 2021, when has been sold 15,000 shares (Class A Common Stock) at a price of $195.44 per share, resulting in proceeds of $2,931,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 955K

12.6% 3M change

7.42% 12M change

Total Value Held $13.1 Million

Serge Saxonov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 06 2021	SELL Open market or private sale	$2,931,600 $195.44 p/Share	15,000 Reduced 1.68%	880,468 Class A Common Stock
Apr 06 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.65%	895,468 Class A Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	24,571 Added 2.64%	905,039 Class A Common Stock
Mar 12 2021	SELL Open market or private sale	$2,353,350 $156.89 p/Share	15,000 Reduced 1.68%	880,468 Class A Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	$123,900 $8.26 p/Share	15,000 Added 1.65%	895,468 Class A Common Stock
Feb 01 2021	SELL Open market or private sale	$1,765,400 $176.54 p/Share	10,000 Reduced 1.12%	880,468 Class A Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$82,600 $8.26 p/Share	10,000 Added 1.11%	890,468 Class A Common Stock
Jan 04 2021	SELL Open market or private sale	$1,404,300 $140.43 p/Share	10,000 Reduced 1.12%	880,468 Class A Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$50,400 $5.04 p/Share	10,000 Added 1.11%	890,468 Class A Common Stock
Dec 22 2020	BUY Exercise of conversion of derivative security	$4,137 $1.14 p/Share	3,629 Added 0.41%	880,468 Class A Common Stock
Dec 14 2020	BUY Bona fide gift	-	15,000 Added 1.68%	876,839 Class A Common Stock
Dec 10 2020	SELL Bona fide gift	-	104,960 Reduced 10.86%	861,839 Class A Common Stock
Dec 08 2020	SELL Bona fide gift	-	382 Reduced 0.04%	966,799 Class A Common Stock
Dec 01 2020	SELL Open market or private sale	$1,520,100 $152.01 p/Share	10,000 Reduced 1.02%	967,181 Class A Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$31,200 $3.12 p/Share	10,000 Added 1.01%	977,181 Class A Common Stock
Nov 03 2020	SELL Open market or private sale	$400,617 $137.01 p/Share	2,924 Reduced 0.3%	967,181 Class A Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$14,737 $5.04 p/Share	2,924 Added 0.3%	970,105 Class A Common Stock
Nov 02 2020	SELL Open market or private sale	$968,068 $136.81 p/Share	7,076 Reduced 0.73%	967,181 Class A Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$22,077 $3.12 p/Share	7,076 Added 0.72%	974,257 Class A Common Stock
Oct 01 2020	SELL Open market or private sale	$1,253,200 $125.32 p/Share	10,000 Reduced 1.02%	967,181 Class A Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$31,200 $3.12 p/Share	10,000 Added 1.01%	977,181 Class A Common Stock

Serge Saxonov

Chief Executive Officer

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account